Hepatitis B Virus Infection and Hepatocellular Carcinoma: Correlation between IgM Antibody to Hepatitis B Core Antigen, Hepatitis B e Antigen, and Hepatitis B DNA

Maria H. Sjogren Department of Virus Diseases, Walter Reed Army Institute of Research, Washington, DC

Search for other papers by Maria H. Sjogren in
Current site
Google Scholar
PubMed
Close
,
Geoffrey M. Dusheiko
Search for other papers by Geoffrey M. Dusheiko in
Current site
Google Scholar
PubMed
Close
,
Michael C. Kew
Search for other papers by Michael C. Kew in
Current site
Google Scholar
PubMed
Close
, and
Ernest Song
Search for other papers by Ernest Song in
Current site
Google Scholar
PubMed
Close
Restricted access

Sera from 102 black patients with primary hepatocellular carcinoma (PHC) and hepatitis B surface antigenemia were tested for immunoglobulin M antibody against hepatitis B core (IgM anti-HBc), hepatitis B e antigen (HBeAg), and hepatitis B viral (HBV) DNA. Their prevalences were compared to those of a control group of 124 age and sex matched black HBV carriers without tumor. IgM anti-HBc was present in 68.6%, HBeAg in 32.3%, and HBV-DNA in 26.7% of the patients. In the control population, IgM anti-HBc was present in 45%, HBeAg was detected in 3.2%, and HBV-DNA in 25.8%. We conclude that IgM anti-HBc is present appreciably more often than either HBeAg or HBV-DNA in patients with PHC. HBeAg or IgM anti-HBc in serum of HBsAg positive carriers may predict an added risk of PHC development in South African blacks.

Author Notes

Save